Skip to content

NC-Stat Modification

by Neurometrix, Inc. 2 variants

510(k) K000565

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK000565 Date27 Jun 2000ClearedStatusActive

Official records

From the FDA record

Received by the FDA
22 Feb 2000
FDA decision
27 Jun 2000 (Substantially Equivalent)
FDA review time
126 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K000565 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Modification to Nc-Stat
510(k) Number
FDA product code
JXE
Device class
Class II
Regulation
21 CFR Part 882.1550
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The NC-Stat Modification is a nerve conduction velocity measurement device, classified under the FDA’s product code JXE. It is designed to assess neuromuscular signals for the diagnosis and evaluation of systemic and entrapment neuropathies, providing quantitative data to aid clinical assessment. This device falls under the broader category of nerve conduction velocity measurement tools, which are critical for diagnosing peripheral nerve disorders.

The NC-Stat Modification is supplied as a reusable medical device and is intended for use in clinical neurology settings. It has received FDA 510(k) clearance under the Traditional pathway, with a decision date of June 27, 2000, and is classified as a Class II device. The modification includes the addition of ulnar distal motor latency (DML) and F-wave capability, expanding its diagnostic functionality while maintaining its original intended use. No regulatory status beyond the stated FDA clearance is implied.

Devices cleared under K000565

6 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K000565
UDI-DISize and differences
ADVANCE NC-S71
NEUROMETRIX, INC.
NC-S7100851221006155 —No longer on the market
ADVANCE NC-S72
NEUROMETRIX, INC.
NC-S7200851221006162 —No longer on the market
ADVANCE NC-S73
NEUROMETRIX, INC.
NC-S7300851221006179 —No longer on the market
ADVANCE NC-S74
NEUROMETRIX, INC.
NC-S7400851221006186 —No longer on the market
ADVANCE NC-S75
NEUROMETRIX, INC.
NC-S7500851221006315 —No longer on the market
ADVANCE NC-S76
NEUROMETRIX, INC.
NC-S7600851221006308 —No longer on the market

Similar devices

Other devices filed under FDA product code JXE (Device, Nerve Conduction Velocity Measurement).

Other devices from Neurometrix, Inc.

See all devices from Neurometrix, Inc. →